Integra LifeSciences Holdings 관리
관리 기준 확인 4/4
Integra LifeSciences Holdings CEO는 Jan De Witte, Dec2021 에 임명되었습니다 의 임기는 2.92 년입니다. 총 연간 보상은 $ 6.39M, 13.7% 로 구성됩니다. 13.7% 급여 및 86.3% 보너스(회사 주식 및 옵션 포함). 는 $ 549.82K 가치에 해당하는 회사 주식의 0.031% 직접 소유합니다. 549.82K. 경영진과 이사회의 평균 재임 기간은 각각 3.6 년과 11.5 년입니다.
주요 정보
Jan De Witte
최고 경영자
US$6.4m
총 보상
| CEO 급여 비율 | 13.7% |
| CEO 임기 | 2.9yrs |
| CEO 소유권 | 0.03% |
| 경영진 평균 재임 기간 | 3.6yrs |
| 이사회 평균 재임 기간 | 11.5yrs |
최근 관리 업데이트
Recent updates
There's No Escaping Integra LifeSciences Holdings Corporation's (NASDAQ:IART) Muted Revenues Despite A 42% Share Price Rise
Nov 05
Is Now The Time To Look At Buying Integra LifeSciences Holdings Corporation (NASDAQ:IART)?
Oct 24Why Investors Shouldn't Be Surprised By Integra LifeSciences Holdings Corporation's (NASDAQ:IART) Low P/S
Sep 08Is Integra LifeSciences Holdings (NASDAQ:IART) A Risky Investment?
Aug 21At US$29.14, Is Integra LifeSciences Holdings Corporation (NASDAQ:IART) Worth Looking At Closely?
Jul 01Integra LifeSciences Still Underperforming As Manufacturing Issues Linger
Jun 21Integra LifeSciences Holdings Corporation's (NASDAQ:IART) Intrinsic Value Is Potentially 40% Above Its Share Price
May 28Returns On Capital At Integra LifeSciences Holdings (NASDAQ:IART) Have Stalled
Feb 27We Think Integra LifeSciences Holdings (NASDAQ:IART) Can Stay On Top Of Its Debt
Feb 11Is Now An Opportune Moment To Examine Integra LifeSciences Holdings Corporation (NASDAQ:IART)?
Jan 14Integra LifeSciences Holdings Corporation's (NASDAQ:IART) Price In Tune With Earnings
Dec 31Is Integra LifeSciences Holdings Corporation (NASDAQ:IART) Trading At A 46% Discount?
Dec 03Does Integra LifeSciences Holdings (NASDAQ:IART) Have A Healthy Balance Sheet?
Nov 06Integra LifeSciences Holdings (NASDAQ:IART) Hasn't Managed To Accelerate Its Returns
Oct 24Is Now An Opportune Moment To Examine Integra LifeSciences Holdings Corporation (NASDAQ:IART)?
Sep 22Is Integra LifeSciences Holdings Corporation (NASDAQ:IART) Trading At A 38% Discount?
Aug 15Returns On Capital At Integra LifeSciences Holdings (NASDAQ:IART) Have Hit The Brakes
Jul 03Is There Now An Opportunity In Integra LifeSciences Holdings Corporation (NASDAQ:IART)?
Jun 19Estimating The Fair Value Of Integra LifeSciences Holdings Corporation (NASDAQ:IART)
May 05These 4 Measures Indicate That Integra LifeSciences Holdings (NASDAQ:IART) Is Using Debt Reasonably Well
Apr 07Integra LifeSciences Holdings (NASDAQ:IART) Is Experiencing Growth In Returns On Capital
Mar 26At US$52.61, Is It Time To Put Integra LifeSciences Holdings Corporation (NASDAQ:IART) On Your Watch List?
Mar 14Does Integra LifeSciences Holdings (NASDAQ:IART) Deserve A Spot On Your Watchlist?
Feb 27Calculating The Fair Value Of Integra LifeSciences Holdings Corporation (NASDAQ:IART)
Feb 02We Think Integra LifeSciences Holdings (NASDAQ:IART) Can Stay On Top Of Its Debt
Jan 05Here's What To Make Of Integra LifeSciences Holdings' (NASDAQ:IART) Decelerating Rates Of Return
Dec 21When Should You Buy Integra LifeSciences Holdings Corporation (NASDAQ:IART)?
Dec 08CEO 보상 분석
| 날짜 | 총 보상 | 급여 | 회사 수익 |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$7m |
| Jun 30 2024 | n/a | n/a | US$24m |
| Mar 31 2024 | n/a | n/a | US$40m |
| Dec 31 2023 | US$6m | US$875k | US$68m |
| Sep 30 2023 | n/a | n/a | US$101m |
| Jun 30 2023 | n/a | n/a | US$131m |
| Mar 31 2023 | n/a | n/a | US$172m |
| Dec 31 2022 | US$9m | US$850k | US$181m |
| Sep 30 2022 | n/a | n/a | US$173m |
| Jun 30 2022 | n/a | n/a | US$166m |
| Mar 31 2022 | n/a | n/a | US$157m |
| Dec 31 2021 | US$899k | US$59k | US$169m |
보상 대 시장: Jan 의 총 보상 ($USD 6.39M )은 US 시장에서 비슷한 규모의 회사의 평균 수준입니다( $USD 5.43M ).
보상과 수익: Jan 의 보상은 지난 한 해 동안 회사 성과와 일치했습니다.
CEO
Jan De Witte (60 yo)
2.9yrs
테뉴어
US$6,388,756
보상
Mr. Jan De Witte has been President, Chief Executive Officer & Director of Integra LifeSciences Holdings Corporation since December 1, 2021. He had been the Chief Executive Officer at Barco NV since Septem...
리더십 팀
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| Executive Chairman | 26.9yrs | US$422.52k | 2.27% $ 40.3m | |
| President | 2.9yrs | US$6.39m | 0.031% $ 549.8k | |
| Executive VP & CFO | 1.4yrs | US$1.67m | 0.054% $ 964.6k | |
| Senior VP of Finance & Principal Accounting Officer | 7.1yrs | US$1.25m | 0.047% $ 830.1k | |
| Executive VP | 6yrs | US$1.62m | 0.082% $ 1.5m | |
| Executive VP & President of Tissue Technologies | 11.9yrs | US$1.42m | 0.084% $ 1.5m | |
| Executive VP & President of Codman Specialty Surgical | 4.5yrs | US$2.83m | 0.075% $ 1.3m | |
| Corporate VP of Global Operations & Supply Chain | 4.3yrs | 데이터 없음 | 데이터 없음 | |
| Vice President of Global Corporate Communications & Public Relations | no data | 데이터 없음 | 데이터 없음 | |
| Vice President of Global Marketing | no data | 데이터 없음 | 데이터 없음 | |
| Executive VP & Chief Human Resources Officer | 1.8yrs | 데이터 없음 | 0.032% $ 560.6k | |
| Corporate VP & Chief Digital Officer | 2.8yrs | 데이터 없음 | 데이터 없음 |
3.6yrs
평균 재임 기간
57yo
평균 연령
경험이 풍부한 관리: IART 의 관리팀은 경험 ( 3.6 년 평균 재직 기간)으로 간주됩니다.
이사회 구성원
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| Executive Chairman | 26.9yrs | US$422.52k | 2.27% $ 40.3m | |
| President | 2.9yrs | US$6.39m | 0.031% $ 549.8k | |
| Independent Director | 15.6yrs | US$297.54k | 0.11% $ 1.9m | |
| Independent Director | 18.8yrs | US$293.28k | 0.082% $ 1.5m | |
| Independent Presiding Director | 11.5yrs | US$342.54k | 0.18% $ 3.1m | |
| Independent Director | 32.8yrs | US$306.31k | 0.091% $ 1.6m | |
| Independent Director | less than a year | US$90.68k | 0.016% $ 287.3k | |
| Independent Director | 3.6yrs | US$260.04k | 0.028% $ 504.2k | |
| Independent Director | 2.3yrs | US$297.54k | 0.021% $ 371.5k |
11.5yrs
평균 재임 기간
63yo
평균 연령
경험이 풍부한 이사회: IART 의 이사회는 노련하고 경험이 있습니다(평균 재직 기간 11.5 년).